![[logo] US EPA](../gif/logo_epaseal.gif){kind=logo}
Guidance for Disinfectant Product Advertising and other Non-label Communication Referring to Enterovirus D68
For Release: December 9, 2014
EPA has established guidance for companies that manufacture or sell disinfectant products that can be used against Enterovirus D68 regarding what can be said in non-label communication for the disinfectants. This guidance is based on criteria established by the Centers for Disease Control and Prevention (CDC) regarding the use of antimicrobial products for disinfection of Enterovirus D68 on environmental surfaces. The full guidance is available online: https://epa.gov/oppad001/enterovirus-d68-guidance.html.
Enterovirus D68 (or EV-D68) is a virus that causes mild to severe respiratory illness. EV-D68 likely spreads from person to person when an infected person coughs, sneezes, or touches a surface that is then touched by others, and thus, surface disinfectants can help prevent the spread of the disease.
Our guidance states that EPA-registered disinfectants with label claims for hospital disinfection (or equivalent microbial pathogen claims) and approved claims against non-enveloped viruses (e.g., norovirus, poliovirus, rhinovirus) are appropriate for use against EV-D68. If a registrant has an EPA-registered product that meets the CDC criteria and if it was either registered after 2010, or EPA has tested the product’s efficacy under the Antimicrobial Testing Program, or EPA has “confirmed” the product’s efficacy, a registrant may say that such a product can be used against EV-D68 on company websites or through other non-label communications. To determine whether EPA has confirmed a product’s efficacy, please refer to the List of ATP-tested Hospital Sterilants, Disinfectants and Tuberculocides (PDF).
Non-label communications should indicate that:
- The product meets the CDC criteria for a disinfectant product with label claims for a non-enveloped virus;
- The product is intended for use on hard, non-porous surfaces; and,
- The product’s label use instructions for the non-enveloped virus or viruses should be followed.
Additional information on Enterovirus D68 is available in the CDC Health Advisory.